FIELD: medicine.
SUBSTANCE: invention consists in a pharmaceutical intranasal composition for influenza prevention, which contains oxidised dextran having a molecular weight of 40-70 kDa in the concentration of 5-10 wt % as an active component, and a pharmaceutically acceptable solvent.
EFFECT: absence of resorbtive action in a combination with an increase in preventive activity and prolonged action of the composition.
2 cl, 3 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| INTRANASAL DRUG FOR INFLUENZA PREVENTION | 2017 |
|
RU2634250C1 |
| MEDICATION FOR PREVENTION OF BIRD FLU IN MAMMALS | 2010 |
|
RU2437664C1 |
| MEANS FOR PREVENTION OF INTERSTITIAL PNEUMONIA | 2020 |
|
RU2747550C1 |
| MEANS AND METHOD FOR PREVENTION OF INTERSTITIAL PNEUMONIA OF INFECTIOUS ETIOLOGY | 2021 |
|
RU2784177C1 |
| ANTI-VIRAL IMMUNOTROPIC AGENT FOR TREATMENT OF ARVI | 2018 |
|
RU2672888C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT OF VIRAL DISEASES | 2010 |
|
RU2438694C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING TICK-BORNE ENCEPHALITIS | 2012 |
|
RU2472504C1 |
| AGENT WITH A GLYCOSYLATED POLYPEPTIDE AND A METHOD FOR PRODUCTION THEREOF | 2019 |
|
RU2712235C1 |
| PHARMACEUTICAL COMPOSITION CONTAINING ENZYME RIBONUCLEASE AND GLYCYRRHIZIC ACID OR SALTS THEREOF: AMMONIUM OR DIPOTASSIUM OR TRISODIUM GLYCYRRHIZINATE | 2012 |
|
RU2504397C1 |
| METHOD FOR TREATING ACUTE RESPIRATORY VIRAL DISEASES AND INFLUENZA | 1995 |
|
RU2107498C1 |
